Stomach Cancer Trial, Recruiting NCT05938309 Sponsor: Fujian Medical University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT05938309
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years old
  • People who have been diagnosed with, or are suspected to have, a type of stomach tumour called a GIST (gastrointestinal stromal tumour), confirmed either before or after surgery through imaging, camera examination, or laboratory analysis of tissue samples
  • People who have agreed to take part and are willing to have keyhole (laparoscopic) surgery on their stomach
  • People whose surgery is expected to remove the tumour completely (no cancer cells left behind)
  • People who are well enough to undergo surgery, based on standard medical fitness assessments (confirm with trial site)

Who may not be able to join:

  • People who are pregnant or breastfeeding
  • People with a serious mental health condition
  • People who have previously had open or major surgery on the upper abdomen, except for keyhole gallbladder removal
  • People who have previously had stomach surgery, except for certain endoscopic procedures to treat early stomach cancer
  • People who have had another type of cancer within the past five years
  • People who have had unstable chest pain (angina) or a heart attack within the past six months
  • People who have had a stroke within the past six months
  • People who have been taking steroid medications continuously for at least one month before joining
  • People who need surgery for another condition at the same time
  • People requiring emergency surgery due to serious complications such as bleeding, blockage, or a hole in the stomach

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613365918502

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Medical University
Registry
ClinicalTrials.gov
Start date
1 May 2023
Est. completion
1 May 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall postoperative morbidity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov